Regulation of neutrophil-mediated killing of Staphylococcus aureus and chemotaxis by c-jun NH2 terminal kinase

Journal of Leukocyte Biology

Volumn 87, Issue 5, 2010, Pages 925-932

  Yeh, Mei Chun ^a,b   Mukaro, Violet ^a,b   Hii, Charles S ^a,b   Ferrante, Antonio ^a,b,c  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Adherence; JNK; Mechanism of bactericidal activity; Phagocytosis; Superoxide production; TAT JIP peptide

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 9; OXYGEN RADICAL; PROTEIN C JUN; ENZYME INHIBITOR; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; BACTERICIDAL ACTIVITY; CELL KILLING; CELL MIGRATION; CHEMOTAXIS; ENZYME ACTIVATION; HUMAN; HUMAN CELL; NEUTROPHIL; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; CELL STRAIN HL 60; DRUG EFFECT; ENZYMOLOGY; IMMUNOLOGY; IMMUNOPRECIPITATION; NEUTROPHIL CHEMOTAXIS; STAPHYLOCOCCUS INFECTION; WESTERN BLOTTING;

STAPHYLOCOCCUS AUREUS;

BLOTTING, WESTERN; CHEMOTAXIS, LEUKOCYTE; ENZYME INHIBITORS; HL-60 CELLS; HUMANS; IMMUNOPRECIPITATION; JNK MITOGEN-ACTIVATED PROTEIN KINASES; NEUTROPHILS; PHAGOCYTOSIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 77952528347     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0609399     Document Type: Article

References (34)

1. Ferrante, A. (2005) Phagocytes, Part 2: neutrophils. In Topley and Wilson's Microbiology and Microbial Infections: Immunology (S. Kaufmann, M. Steward, eds.), London, UK, Arnold, 35-55.
2. Schnyder, B., Meunier, P. C., Car, B. D. (1998) Inhibition of kinases impairs neutrophil activation and killing of Staphylococcus aureus. Biochem. J. 331, 489-495. (Pubitemid 28182164)
3. Hii, C. S., Stacey, K., Moghaddami, N., Murray, A. W., Ferrante, A. (1999) Role of the extracellular signal-regulated protein kinase cascade in human neutrophil killing of Staphylococcus aureus and Candida albicans and in migration. Infect. Immun. 67, 1297-1302. (Pubitemid 29108508)
4. Barr, R. K., Kendrick, T. S., Bogoyevitch, M. A. (2002) Identification of the critical features of a small peptide inhibitor of JNK activity. J. Biol. Chem. 277, 10987-10997.
5. Dickens, M., Rogers, J. S., Cavanagh, J., Raitano, A., Xia, Z., Halpern, J. R., Greenberg, M. E., Sawyers, C. L., Davis, R. J. (1997) A cytoplasmic inhibitor of the JNK signal transduction pathway. Science 277, 693-696. (Pubitemid 27373916)
6. Wadia, J. S., Dowdy, S. F. (2005) Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer. Adv. Drug Deliv. Rev. 57, 579-596. (Pubitemid 40255562)
7. Bonny, C., Oberson, A., Negri, S., Sauser, C., Schorderet, D. F. (2001) Cell-permeable peptide inhibitors of JNK: novel blockers of β-cell death. Diabetes 50, 77-82. (Pubitemid 32047984)
8. Ferrante, A., Robinson, B. S., Singh, H., Jersmann, H. P., Ferrante, J. V., Huang, Z. H., Trout, N. A., Pitt, M. J., Rathjen, D. A., Easton, C. J., Poulos, A., Prager, R. H., Lee, F. S., Hii, C. S. (2006) A novel β-oxa polyunsaturated fatty acid downregulates the activation of the IκB kinase/nuclear factor κB pathway, inhibits expression of endothelial cell adhesion molecules, and depresses inflammation. Circ. Res. 99, 34-41.
9. Ferrante, A., Martin, A. J., Bates, E. J., Kowanko, I. C., Harvey, D. P., Parsons, D., Rathjen, D. A., Russ, G., Dayer, J. M. (1994) Interaction of Staphylococcus aureus with human neutrophils and the down-regulation of TNF receptors. J. Immunol. 152, 3998-4004.
10. Gyllenhammar, H. (1987) Lucigenin chemiluminescence in the assessment of neutrophil superoxide production. J. Immunol. Methods 97, 209-213. (Pubitemid 17026185)
11. Weingart, C. L., Broitman-Maduro, G., Dean, G., Newman, S., Peppler, M., Weiss, A. A. (1999) Fluorescent labels influence phagocytosis of Bordetella pertussis by human neutrophils. Infect. Immun. 67, 4264-4267. (Pubitemid 29357056)
12. Hii, C. S., Anson, D. S., Costabile, M., Mukaro, V., Dunning, K., Ferrante, A. (2004) Characterization of the MEK5-ERK5 module in human neutrophils and its relationship to ERK1/ERK2 in the chemotactic response. J. Biol. Chem. 279, 49825-49834. (Pubitemid 39577788)
13. Hii, C. S., Huang, Z. H., Bilney, A., Costabile, M., Murray, A. W., Rathjen, D. A., Der, C. J., Ferrante, A. (1998) Stimulation of p38 phosphorylation and activity by arachidonic acid in HeLa cells, HL60 promyelocytic leukemic cells, and human neutrophils. Evidence for cell type-specific activation of mitogen-activated protein kinases. J. Biol. Chem. 273, 19277-19282.
14. Costabile, M., Hii, C. S., Robinson, B. S., Rathjen, D. A., Pitt, M., Easton, C., Miller, R. C., Poulos, A., Murray, A. W., Ferrante, A. (2001) A novel long chain polyunsaturated fatty acid, β-Oxa 21:3n-3, inhibits T lymphocyte proliferation, cytokine production, delayed-type hypersensitivity, and carrageenan-induced paw reaction and selectively targets intracellular signals. J. Immunol. 167, 3980-3987.
15. Bain, J., Plater, L., Elliott, M., Shpiro, N., Hastie, C. J., McLauchlan, H., Klevernic, I., Arthur, J. S., Alessi, D. R., Cohen, P. (2007) The selectivity of protein kinase inhibitors: a further update. Biochem. J. 408, 297-315.
16. Reeves, E. P., Lu, H., Jacobs, H. L., Messina, C. G., Bolsover, S., Gabella, G., Potma, E. O., Warley, A., Roes, J., Segal, A. W. (2002) Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature 416, 291-297. (Pubitemid 34260237)
17. Thong, Y. H., Ferrante, A., Ness, D. (1977) Neutrophil phagocytic and bactericidal dysfunction induced by bilirubin. Aust. Paediatr. J. 13, 287-289. (Pubitemid 8281452)
18. Arthur, P. G., Matich, G. P., Pang, W. W., Yu, D. Y., Bogoyevitch, M. A. (2007) Necrotic death of neurons following an excitotoxic insult is prevented by a peptide inhibitor of c-jun N-terminal kinase. J. Neurochem. 102, 65-76.
19. Melino, M., Hii, C. S., McColl, S. R., Ferrante, A. (2008) The effect of the JNK inhibitor, JIP peptide, on human T lymphocyte proliferation and cytokine production. J. Immunol. 181, 7300-7306.
20. Chen, Y. R., Meyer, C. F., Tan, T. H. (1996) Persistent activation of c-jun N-terminal kinase 1 (JNK1) in γ radiation-induced apoptosis. J. Biol. Chem. 271, 631-634.
21. Wang, X., Martindale, J. L., Liu, Y., Holbrook, N. J. (1998) The cellular response to oxidative stress: influences of mitogen-activated protein kinase signaling pathways on cell survival. Biochem. J. 333, 291-300. (Pubitemid 28379529)
22. Hu, Y. L., Li, S., Shyy, J. Y., Chien, S. (1999) Sustained JNK activation induces endothelial apoptosis: studies with colchicine and shear stress. Am. J. Physiol. 277, H1593-H1599.
23. Guo, Y. L., Kang, B., Williamson, J. R. (1998) Inhibition of the expression of mitogen-activated protein phosphatase-1 potentiates apoptosis induced by tumor necrosis factor-α in rat mesangial cells. J. Biol. Chem. 273, 10362-10366. (Pubitemid 28227643)
24. Widmann, C., Johnson, N. L., Gardner, A. M., Smith, R. J., Johnson, G. L. (1997) Potentiation of apoptosis by low dose stress stimuli in cells expressing activated MEK kinase 1. Oncogene 15, 2439-2447. (Pubitemid 27503530)
25. Kato, T., Noma, H., Kitagawa, M., Takahashi, T., Oshitani, N., Kitagawa, S. (2008) Distinct role of c-jun N-terminal kinase isoforms in human neutrophil apoptosis regulated by tumor necrosis factor-α and granulocyte-macrophage colony-stimulating factor. J. Interferon Cytokine Res. 28, 235-243. (Pubitemid 351591446)
26. Arndt, P. G., Young, S. K., Worthen, G. S. (2005) Regulation of lipopolysaccharide- induced lung inflammation by plasminogen activator inhibitor- 1 through a JNK-mediated pathway. J. Immunol. 175, 4049-4059.
27. Arndt, P. G., Young, S. K., Lieber, J. G., Fessler, M. B., Nick, J. A., Worthen, G. S. (2005) Inhibition of c-jun N-terminal kinase limits lipopolysaccharide- induced pulmonary neutrophil influx. Am. J. Respir. Crit. Care Med. 171, 978-986.
28. McLeish, K. R., Klein, J. B., Coxon, P. Y., Head, K. Z., Ward, R. A. (1998) Bacterial phagocytosis activates extracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascades in human neutrophils. J. Leukoc. Biol. 64, 835-844.
29. Ferrante, A., Beard, L. J., Thong, Y. H. (1980) Early decay of human neutrophil chemotactic responsiveness following isolation from peripheral blood. Clin. Exp. Immunol. 39, 532-537.
30. Fuchs, S. Y., Dolan, L., Davis, R. J., Ronai, Z. (1996) Phosphorylation-dependent targeting of c-jun ubiquitination by jun N-kinase. Oncogene 13, 1531-1535. (Pubitemid 26354201)
31. Musti, A. M., Treier, M., Bohmann, D. (1997) Reduced ubiquitin-dependent degradation of c-jun after phosphorylation by MAP kinases. Science 275, 400-402. (Pubitemid 27051620)
32. Treier, M., Staszewski, L. M., Bohmann, D. (1994) Ubiquitin-dependent c-jun degradation in vivo is mediated by the δ domain. Cell 78, 787-798. (Pubitemid 24294454)
33. Angel, P., Hattori, K., Smeal, T., Karin, M. (1988) The jun proto-oncogene is positively autoregulated by its product, jun/AP-1. Cell 55, 875-885.
34. Kayahara, M., Wang, X., Tournier, C. (2005) Selective regulation of c-jun gene expression by mitogen-activated protein kinases via the 12-o-tetradecanoylphorbol- 13-acetate-responsive element and myocyte enhancer factor 2 binding sites. Mol. Cell. Biol. 25, 3784-3792. (Pubitemid 40559583)